Bank of New York Mellon Corp Buys Shares of 488,085 Maximus, Inc. $MMS

Key Points

• Bank of New York Mellon acquired 488,085 Maximus shares worth approximately $26.2 million, representing a 0.93% stake. Institutional investors collectively own 97.21% of the company.
• Maximus slightly exceeded quarterly EPS expectations at $2.22 but reported revenue of $1.28 billion, below the $1.33 billion consensus and down 5.1% year over year. The company’s fiscal 2026 EPS guidance is $7.90–$8.20.
• Analyst sentiment remains cautious: Zacks downgraded the stock to “Strong Sell,” while the broader average rating is “Reduce.” Shares opened at $59.73, below their 200-day moving average of $63.63, despite a quarterly dividend yielding about 2.2%.

Bank of New York Mellon Corp purchased a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 488,085 shares of the health services provider's stock, valued at approximately $26,239,000. Bank of New York Mellon Corp owned 0.93% of Maximus as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of MMS. Reinhart Partners LLC. grew its position in Maximus by 131.8% in the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock valued at $106,575,000 after acquiring an additional 1,127,346 shares during the last quarter. Norges Bank purchased a new stake in shares of Maximus during the fourth quarter valued at $60,393,000. River Road Asset Management LLC boosted its stake in shares of Maximus by 236.1% during the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider's stock valued at $71,064,000 after purchasing an additional 578,326 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Maximus by 218.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider's stock valued at $50,379,000 after purchasing an additional 400,315 shares during the period. Finally, Walleye Capital LLC bought a new position in shares of Maximus in the second quarter worth about $20,645,000. 97.21% of the stock is owned by institutional investors.

More Maximus News

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Zacks raised its FY2028 EPS forecast to $9.15 from $8.94, while also increasing estimates for Q1 2028, Q2 2028 and Q3 2028. The revisions suggest expectations for longer-term earnings growth remain intact.
• Neutral Sentiment: The analyst made several offsetting changes to its forecasts, including higher estimates for Q2 2027 and lower estimates for Q1 2027, Q3 2027 and Q4 2027. Zacks projects FY2027 EPS of $8.37 and FY2028 EPS of $9.15, but retains a “Strong Sell” rating.
• Negative Sentiment: Zacks cut its FY2026 EPS estimate to $8.07 from $8.41 and reduced its Q4 2026 forecast to $1.93 from $2.29. The FY2026 estimate is only slightly above the broader consensus of $8.03, indicating limited near-term earnings upside and creating pressure on the shares.
• Negative Sentiment: The negative revisions follow Maximus’ latest quarterly results, which showed revenue below expectations and a 5.1% year-over-year decline, despite a small EPS beat. With shares still below their 200-day moving average, investors may remain focused on contracting revenue and the risk that government-services demand or contract timing could weigh on earnings.

Maximus Price Performance

Shares of MMS stock opened at $59.73 on Friday. Maximus, Inc. has a 1-year low of $52.73 and a 1-year high of $100.00. The stock's 50-day moving average is $57.66 and its 200 day moving average is $63.63. The company has a market cap of $3.13 billion, a P/E ratio of 8.82 and a beta of 0.59. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The firm's revenue was down 5.1% on a year-over-year basis. During the same period in the previous year, the company posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Research analysts predict that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus's dividend payout ratio is presently 19.50%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on MMS shares. Zacks Research lowered shares of Maximus from a "hold" rating to a "strong sell" rating in a research report on Tuesday, August 11th. Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a report on Monday, August 17th. Finally, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Reduce".

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source